XML 23 R11.htm IDEA: XBRL DOCUMENT
v3.23.3

Restatement of consolidated financial statements | 12 Months Ended
--- | ---
Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract] |
Restatement of consolidated financial statements | Restatement of consolidated financial statements As part of the Company's quarterly review process related to the preparation of its unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2023, the Company determined that its net state deferred tax liability was overstated as of December 31, 2022, resulting in an understatement of the income tax benefits reflected on the Company's consolidated statement of operations. This material error was associated with the use of incorrect state tax rates in the calculation of state deferred tax assets and related valuation allowances, which are non-cash items that resulted in an understatement of the Company's income tax benefit of $11.7 million for the year ended December 31, 2022. In connection with the restatement to correct this material error, the Company determined that it is appropriate to revise the financial statements as of and for the years ending December 31, 2022, 2021 and 2020 included in this Form 10-K/A to correct other unrelated immaterial errors that were previously either unrecorded or recorded as out-of-period adjustments. The following tables present the impact of the financial statement adjustments on the Company's previously reported consolidated financial statements for the fiscal years ended December 31, 2022, 2021 and 2020. The "Previously Reported" amounts in the following tables are amounts derived from the Original Form 10-K filed with the United States Securities and Exchange Commission on March 1, 2023. The amounts in the columns labeled "Tax Adjustments" represent the effect of adjustments resulting from the correction of the overstatement of the Company's net state deferred tax liability and understatement of the income tax benefits of $11.7 million and the tax impact of all other individually immaterial non-tax adjustments of $2.2 million for the year ended December 31, 2022. The amounts in the columns labeled "Other Adjustments" represent the effect of other adjustments that relate to other unrelated errors in previously filed financial statements that were not material, individually or in the aggregate, to those filed financial statements. The effects of both the restatement for the Tax Adjustments and the revisions for the Other Adjustments have been corrected in all impacted tables and footnotes throughout these consolidated financial statements. The following table presents the impact of the financial statement adjustments on the Company's previously reported Consolidated Balance Sheets for the years ended December 31, 2022 and 2021:
|  | As of |  | As of
|  | December 31, 2022 |  | December 31, 2021
|  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated |  | Previously Reported |  | Other Adjustments |  | As Revised
ASSETS |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 642.6 |  |  | $ | — |  |  | $ | — |  |  | $ | 642.6 |  |  | $ | 576.1 |  |  | $ | — |  |  | $ | 576.1 |
Restricted cash |  | — |  |  | — |  |  | — |  |  | — |  |  | 0.2 |  |  | — |  |  | 0.2 |
Accounts receivable, net |  | 158.4 |  |  | — |  |  | 0.8 |  |  | 159.2 |  |  | 274.7 |  |  | 4.2 |  |  | 278.9 |
Inventories, net |  | 351.8 |  |  | — |  |  | (1.1) |  |  | 350.7 |  |  | 350.8 |  |  | (6.3) |  |  | 344.5 |
Prepaid expenses and other current assets |  | 57.9 |  |  | — |  |  | — |  |  | 57.9 |  |  | 70.2 |  |  | — |  |  | 70.2 |
Total current assets |  | 1,210.7 |  |  | — |  |  | (0.3) |  |  | 1,210.4 |  |  | 1,272.0 |  |  | (2.1) |  |  | 1,269.9 |
Property, plant and equipment, net |  | 817.6 |  |  | — |  |  | — |  |  | 817.6 |  |  | 800.1 |  |  | — |  |  | 800.1 |
Intangible assets, net |  | 728.8 |  |  | — |  |  | — |  |  | 728.8 |  |  | 604.6 |  |  | — |  |  | 604.6 |
Goodwill |  | 218.2 |  |  | — |  |  | — |  |  | 218.2 |  |  | 224.9 |  |  | — |  |  | 224.9 |
Other assets |  | 191.3 |  |  | — |  |  | — |  |  | 191.3 |  |  | 57.4 |  |  | 0.8 |  |  | 58.2 |
Total assets |  | $ | 3,166.6 |  |  | $ | — |  |  | $ | (0.3) |  |  | $ | 3,166.3 |  |  | $ | 2,959.0 |  |  | $ | (1.3) |  |  | $ | 2,957.7 |
LIABILITIES AND STOCKHOLDERS' EQUITY |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  | $ | 103.5 |  |  | $ | — |  |  | $ | — |  |  | $ | 103.5 |  |  | $ | 128.9 |  |  | $ | — |  |  | $ | 128.9 |
Accrued expenses |  | 34.9 |  |  | — |  |  | — |  |  | 34.9 |  |  | 51.7 |  |  | — |  |  | 51.7 |
Accrued compensation |  | 88.3 |  |  | — |  |  | (1.0) |  |  | 87.3 |  |  | 88.7 |  |  | — |  |  | 88.7 |
Debt, current portion |  | 957.3 |  |  | — |  |  | — |  |  | 957.3 |  |  | 31.6 |  |  | — |  |  | 31.6 |
Other current liabilities |  | 45.9 |  |  | (0.3) |  |  | 0.3 |  |  | 45.9 |  |  | 72.9 |  |  | 0.2 |  |  | 73.1 |
Total current liabilities |  | 1,229.9 |  |  | (0.3) |  |  | (0.7) |  |  | 1,228.9 |  |  | 373.8 |  |  | 0.2 |  |  | 374.0 |
Debt, net of current portion |  | 448.5 |  |  | — |  |  | — |  |  | 448.5 |  |  | 809.4 |  |  | — |  |  | 809.4 |
Deferred tax liability |  | 71.8 |  |  | (12.1) |  |  | — |  |  | 59.7 |  |  | 94.9 |  |  | (1.6) |  |  | 93.3 |
Other liabilities |  | 33.4 |  |  | 7.1 |  |  | 1.0 |  |  | 41.5 |  |  | 61.9 |  |  | 7.6 |  |  | 69.5 |
Total liabilities |  | 1,783.6 |  |  | (5.3) |  |  | 0.3 |  |  | 1,778.6 |  |  | 1,340.0 |  |  | 6.2 |  |  | 1,346.2 |
Stockholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Preferred stock, $0.001 par value; 15.0 shares authorized, no shares issued and outstanding |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Common stock, $0.001 par value; 200.0 shares authorized, 55.7 and 55.1 shares issued; 50.1 and 51.3 shares outstanding, respectively. |  | 0.1 |  |  | — |  |  | — |  |  | 0.1 |  |  | 0.1 |  |  | — |  |  | 0.1 |
Treasury stock, at cost, 5.6 and 3.8 common shares, respectively |  | (227.7) |  |  | — |  |  | — |  |  | (227.7) |  |  | (152.2) |  |  | — |  |  | (152.2) |
Additional paid-in capital |  | 873.5 |  |  | — |  |  | — |  |  | 873.5 |  |  | 829.4 |  |  | — |  |  | 829.4 |
Accumulated other comprehensive income (loss), net |  | 3.1 |  |  | — |  |  | — |  |  | 3.1 |  |  | (16.1) |  |  | — |  |  | (16.1) |
Retained earnings |  | 734.0 |  |  | 5.3 |  |  | (0.6) |  |  | 738.7 |  |  | 957.8 |  |  | (7.5) |  |  | 950.3 |
Total stockholders’ equity |  | 1,383.0 |  |  | 5.3 |  |  | (0.6) |  |  | 1,387.7 |  |  | 1,619.0 |  |  | (7.5) |  |  | 1,611.5 |
Total liabilities and stockholders’ equity |  | $ | 3,166.6 |  |  | $ | — |  |  | $ | (0.3) |  |  | $ | 3,166.3 |  |  | $ | 2,959.0 |  |  | $ | (1.3) |  |  | $ | 2,957.7 |
The following tables present the impact of the financial statement adjustments on the Company's previously reported Consolidated Statements of Operations for the years ended December 31, 2022, 2021 and 2020:
|  | Year Ended |  | Year Ended
|  | December 31, 2022 |  | December 31, 2021
|  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated |  | Previously Reported |  | Other Adjustments |  | As Revised
Revenues: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Product sales, net |  | $ | 966.2 |  |  | $ | — |  |  | $ | — |  |  | $ | 966.2 |  |  | $ | 1,023.9 |  |  | $ | — |  |  | $ | 1,023.9 |
CDMO: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Services |  | 108.4 |  |  | — |  |  | (3.4) |  |  | 105.0 |  |  | 334.9 |  |  | (24.6) |  |  | 310.3 |
Leases |  | 4.9 |  |  | — |  |  | — |  |  | 4.9 |  |  | 299.7 |  |  | 5.5 |  |  | 305.2 |
Total CDMO |  | 113.3 |  |  | — |  |  | (3.4) |  |  | 109.9 |  |  | 634.6 |  |  | (19.1) |  |  | 615.5 |
Contracts and grants |  | 41.4 |  |  | — |  |  | — |  |  | 41.4 |  |  | 134.2 |  |  | — |  |  | 134.2 |
Total revenues |  | 1,120.9 |  |  | — |  |  | (3.4) |  |  | 1,117.5 |  |  | 1,792.7 |  |  | (19.1) |  |  | 1,773.6 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of product sales |  | 424.1 |  |  | — |  |  | 0.5 |  |  | 424.6 |  |  | 382.0 |  |  | 0.6 |  |  | 382.6 |
Cost of CDMO |  | 269.6 |  |  | — |  |  | (1.1) |  |  | 268.5 |  |  | 375.5 |  |  | (10.0) |  |  | 365.5 |
Research and development |  | 193.0 |  |  | — |  |  | (4.7) |  |  | 188.3 |  |  | 234.0 |  |  | 1.2 |  |  | 235.2 |
Selling, general and administrative |  | 340.3 |  |  | — |  |  | (0.8) |  |  | 339.5 |  |  | 348.4 |  |  | 0.3 |  |  | 348.7 |
Goodwill impairment |  | 6.7 |  |  | — |  |  | — |  |  | 6.7 |  |  | 41.7 |  |  | — |  |  | 41.7 |
Amortization of intangible assets |  | 59.9 |  |  | — |  |  | — |  |  | 59.9 |  |  | 58.5 |  |  | — |  |  | 58.5 |
Total operating expenses |  | 1,293.6 |  |  | — |  |  | (6.1) |  |  | 1,287.5 |  |  | 1,440.1 |  |  | (7.9) |  |  | 1,432.2 |
Income (loss) from operations |  | (172.7) |  |  | — |  |  | 2.7 |  |  | (170.0) |  |  | 352.6 |  |  | (11.2) |  |  | 341.4 |
Other income (expense): |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense |  | (37.3) |  |  | — |  |  | — |  |  | (37.3) |  |  | (34.5) |  |  | — |  |  | (34.5) |
Other, net |  | (11.7) |  |  | — |  |  | — |  |  | (11.7) |  |  | (3.7) |  |  | — |  |  | (3.7) |
Total other income (expense), net |  | (49.0) |  |  | — |  |  | — |  |  | (49.0) |  |  | (38.2) |  |  | — |  |  | (38.2) |
Income (loss) before income taxes |  | (221.7) |  |  | — |  |  | 2.7 |  |  | (219.0) |  |  | 314.4 |  |  | (11.2) |  |  | 303.2 |
Income tax (benefit) provision |  | 2.1 |  |  | (9.5) |  |  | — |  |  | (7.4) |  |  | 83.5 |  |  | 0.2 |  |  | 83.7 |
Net income (loss) |  | $ | (223.8) |  |  | $ | 9.5 |  |  | $ | 2.7 |  |  | $ | (211.6) |  |  | $ | 230.9 |  |  | $ | (11.4) |  |  | $ | 219.5 |
Net income (loss) per common share |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (4.47) |  |  | $ | 0.19 |  |  | $ | 0.06 |  |  | $ | (4.22) |  |  | $ | 4.32 |  |  | $ | (0.22) |  |  | $ | 4.10 |
Diluted |  | $ | (4.47) |  |  | $ | 0.19 |  |  | $ | 0.06 |  |  | $ | (4.22) |  |  | $ | 4.27 |  |  | $ | (0.21) |  |  | $ | 4.06 |
Shares used in computing net income (loss) per common share |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | 50.1 |  |  | — |  |  | — |  |  | 50.1 |  |  | 53.5 |  |  | — |  |  | 53.5 |
Diluted |  | 50.1 |  |  | — |  |  | — |  |  | 50.1 |  |  | 54.1 |  |  | — |  |  | 54.1 |
|  | Year Ended
|  | December 31, 2020
|  | Previously Reported |  | Other Adjustments |  | As Revised
Revenues: |  |  |  |  |  |
Product sales, net |  | $ | 989.8 |  |  | $ | — |  |  | $ | 989.8 |
CDMO: |  |  |  |  |  |
Services |  | 166.7 |  |  | 27.4 |  |  | 194.1 |
Leases |  | 283.8 |  |  | (5.5) |  |  | 278.3 |
Total CDMO |  | 450.5 |  |  | 21.9 |  |  | 472.4 |
Contracts and grants |  | 115.1 |  |  | — |  |  | 115.1 |
Total revenues |  | 1,555.4 |  |  | 21.9 |  |  | 1,577.3 |
Operating expenses: |  |  |  |  |  |
Cost of product sales |  | 392.0 |  |  | — |  |  | 392.0 |
Cost of CDMO |  | 132.0 |  |  | 13.0 |  |  | 145.0 |
Research and development |  | 234.5 |  |  | 3.4 |  |  | 237.9 |
Selling, general and administrative |  | 303.3 |  |  | 0.8 |  |  | 304.1 |
Amortization of intangible assets |  | 59.8 |  |  | — |  |  | 59.8 |
Total operating expenses |  | 1,121.6 |  |  | 17.2 |  |  | 1,138.8 |
Income from operations |  | 433.8 |  |  | 4.7 |  |  | 438.5 |
Other income (expense): |  |  |  |  |  |
Interest expense |  | (31.3) |  |  | — |  |  | (31.3) |
Other, net |  | 4.7 |  |  | — |  |  | 4.7 |
Total other income (expense), net |  | (26.6) |  |  | — |  |  | (26.6) |
Income before income taxes |  | 407.2 |  |  | 4.7 |  |  | 411.9 |
Income tax provision |  | 102.1 |  |  | 4.0 |  |  | 106.1 |
Net income |  | $ | 305.1 |  |  | $ | 0.7 |  |  | $ | 305.8 |
Net income per common share |  |  |  |  |  |
Basic |  | $ | 5.79 |  |  | $ | 0.01 |  |  | $ | 5.80 |
Diluted |  | $ | 5.67 |  |  | $ | 0.01 |  |  | $ | 5.68 |
Shares used in computing net income (loss) per common share |  |  |  |  |  |
Basic |  | 52.7 |  |  | — |  |  | 52.7 |
Diluted |  | 53.8 |  |  | — |  |  | 53.8 |
The following table presents the impact of the financial statement adjustments on the Company's previously reported Consolidated Statements of Cash Flows for the years ended December 31, 2022, 2021 and 2020:
|  | Year Ended
|  | December 31, 2022
|  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated
Operating Activities |  |  |  |  |  |  |  |
Net loss |  | $ | (223.8) |  |  | $ | 9.5 |  |  | $ | 2.7 |  |  | $ | (211.6) |
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |
Stock-based compensation expense |  | 45.1 |  |  | — |  |  | — |  |  | 45.1 |
Depreciation and amortization |  | 143.3 |  |  | — |  |  | — |  |  | 143.3 |
Change in fair value of contingent obligations, net |  | 2.6 |  |  | — |  |  | — |  |  | 2.6 |
Amortization of deferred financing costs |  | 4.1 |  |  | — |  |  | — |  |  | 4.1 |
Impairments |  | 6.7 |  |  | — |  |  | — |  |  | 6.7 |
Deferred income taxes |  | (19.0) |  |  | (9.6) |  |  | — |  |  | (28.6) |
Other |  | 6.4 |  |  | — |  |  | — |  |  | 6.4 |
Changes in operating assets and liabilities: |  |  |  |  |  |  |  |
Accounts receivable |  | 114.7 |  |  | — |  |  | 3.4 |  |  | 118.1 |
Inventories |  | (51.9) |  |  | — |  |  | (5.2) |  |  | (57.1) |
Prepaid expenses and other assets |  | (19.9) |  |  | — |  |  | — |  |  | (19.9) |
Accounts payable |  | (14.0) |  |  | — |  |  | — |  |  | (14.0) |
Accrued expenses and other liabilities |  | (66.7) |  |  | — |  |  | — |  |  | (66.7) |
Accrued compensation |  | 0.1 |  |  | — |  |  | (0.9) |  |  | (0.8) |
Income taxes receivable and payable, net |  | 28.6 |  |  | 0.1 |  |  | — |  |  | 28.7 |
Contract liabilities |  | 9.6 |  |  | — |  |  | — |  |  | 9.6 |
Net cash used in operating activities |  | (34.1) |  |  | — |  |  | — |  |  | (34.1) |
Investing Activities |  |  |  |  |  |  |  |
Purchases of property, plant and equipment |  | (115.8) |  |  | — |  |  | — |  |  | (115.8) |
Royalty settlement payment |  | (21.8) |  |  | — |  |  | — |  |  | (21.8) |
Asset acquisitions |  | (243.7) |  |  | — |  |  | — |  |  | (243.7) |
Net cash used in investing activities |  | (381.3) |  |  | — |  |  | — |  |  | (381.3) |
Financing Activities |  |  |  |  |  |  |  |
Purchases of treasury stock |  | (82.1) |  |  | — |  |  | — |  |  | (82.1) |
Proceeds from revolving credit facility |  | 598.0 |  |  | — |  |  | — |  |  | 598.0 |
Principal payments on term loan facility |  | (33.8) |  |  | — |  |  | — |  |  | (33.8) |
Proceeds from stock-based compensation activity |  | 5.0 |  |  | — |  |  | — |  |  | 5.0 |
Taxes paid for stock-based compensation activity |  | (5.9) |  |  | — |  |  | — |  |  | (5.9) |
Net cash provided by financing activities: |  | 481.2 |  |  | — |  |  | — |  |  | 481.2 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  | 0.5 |  |  | — |  |  | — |  |  | 0.5 |
Net change in cash, cash equivalents and restricted cash |  | 66.3 |  |  | — |  |  | — |  |  | 66.3 |
Cash, cash equivalents and restricted cash, beginning of period |  | 576.3 |  |  | — |  |  | — |  |  | 576.3 |
Cash, cash equivalents and restricted cash, end of period |  | $ | 642.6 |  |  | $ | — |  |  | $ | — |  |  | $ | 642.6 |
Supplemental disclosure of cash flow information: |  |  |  |  |  |  |  |
Cash paid for interest |  | $ | 33.0 |  |  | $ | — |  |  | $ | — |  |  | $ | 33.0 |
Cash paid for income taxes |  | $ | 6.2 |  |  | $ | — |  |  | $ | — |  |  | $ | 6.2 |
Supplemental information on non-cash investing and financing activities: |  |  |  |  |  |  |  |
Purchases of property, plant and equipment unpaid at period end |  | $ | 9.4 |  |  | $ | — |  |  | $ | — |  |  | $ | 9.4 |
Purchases of treasury stock unpaid at period end |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Reconciliation of cash and cash equivalents and restricted cash: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 642.6 |  |  | $ | — |  |  | $ | — |  |  | $ | 642.6 |
Restricted cash |  | — |  |  | — |  |  | — |  |  | — |
Total |  | $ | 642.6 |  |  | $ | — |  |  | $ | — |  |  | $ | 642.6 |
|  | Year Ended
|  | December 31, 2021
|  | Previously Reported |  | Other Adjustments |  | As Revised
Operating Activities |  |  |  |  |  |
Net income (loss) |  | $ | 230.9 |  |  | $ | (11.4) |  |  | $ | 219.5 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |  |  |
Stock-based compensation expense |  | 42.4 |  |  | — |  |  | 42.4 |
Depreciation and amortization |  | 123.8 |  |  | — |  |  | 123.8 |
Change in fair value of contingent obligations, net |  | 2.9 |  |  | — |  |  | 2.9 |
Amortization of deferred financing costs |  | 4.1 |  |  | — |  |  | 4.1 |
Impairments |  | 41.7 |  |  | — |  |  | 41.7 |
Deferred income taxes |  | 46.9 |  |  | (0.9) |  |  | 46.0 |
Write off of contract asset and liability |  | (17.2) |  |  | — |  |  | (17.2) |
Other |  | 2.0 |  |  | — |  |  | 2.0 |
Changes in operating assets and liabilities: |  |  |  |  |  |
Accounts receivable |  | (48.2) |  |  | 32.0 |  |  | (16.2) |
Inventories |  | (44.0) |  |  | (22.6) |  |  | (66.6) |
Prepaid expenses and other assets |  | 7.7 |  |  | — |  |  | 7.7 |
Accounts payable |  | (2.5) |  |  | 0.9 |  |  | (1.6) |
Accrued expenses and other liabilities |  | (9.2) |  |  | — |  |  | (9.2) |
Accrued compensation |  | 4.0 |  |  | — |  |  | 4.0 |
Income taxes receivable and payable, net |  | (32.4) |  |  | 1.1 |  |  | (31.3) |
Contract liabilities |  | (31.8) |  |  | — |  |  | (31.8) |
Net cash provided by operating activities |  | 321.1 |  |  | (0.9) |  |  | 320.2 |
Investing Activities |  |  |  |  |  |
Purchases of property, plant and equipment |  | (225.0) |  |  | 0.9 |  |  | (224.1) |
Net cash used in investing activities |  | (225.0) |  |  | 0.9 |  |  | (224.1) |
Financing Activities |  |  |  |  |  |
Purchases of treasury stock |  | (106.0) |  |  | — |  |  | (106.0) |
Proceeds from senior unsecured notes |  | — |  |  | — |  |  | — |
Principal payments on convertible senior notes |  | (10.6) |  |  | — |  |  | (10.6) |
Principal payments on term loan facility |  | (25.3) |  |  | — |  |  | (25.3) |
Proceeds from stock-based compensation activity |  | 15.9 |  |  | — |  |  | 15.9 |
Taxes paid for stock-based compensation activity |  | (13.8) |  |  | — |  |  | (13.8) |
Contingent consideration payments |  | (1.2) |  |  | — |  |  | (1.2) |
Net cash used in financing activities: |  | (141.0) |  |  | — |  |  | (141.0) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  | (0.3) |  |  | — |  |  | (0.3) |
Net change in cash, cash equivalents and restricted cash |  | (45.2) |  |  | — |  |  | (45.2) |
Cash, cash equivalents and restricted cash, beginning of period |  | 621.5 |  |  | — |  |  | 621.5 |
Cash, cash equivalents and restricted cash, end of period |  | $ | 576.3 |  |  | $ | — |  |  | $ | 576.3 |
Supplemental disclosure of cash flow information: |  |  |  |  |  |
Cash paid for interest |  | $ | 30.4 |  |  | $ | — |  |  | $ | 30.4 |
Cash paid for income taxes |  | $ | 71.6 |  |  | $ | — |  |  | $ | 71.6 |
Supplemental information on non-cash investing and financing activities: |  |  |  |  |  |
Purchases of property, plant and equipment unpaid at period end |  | $ | 20.0 |  |  | $ | — |  |  | $ | 20.0 |
Purchases of treasury stock unpaid at period end |  | $ | 6.6 |  |  | $ | — |  |  | $ | 6.6 |
Reconciliation of cash and cash equivalents and restricted cash: |  |  |  |  |  |
Cash and cash equivalents |  | $ | 576.1 |  |  | $ | — |  |  | $ | 576.1 |
Restricted cash |  | 0.2 |  |  | — |  |  | 0.2 |
Total |  | $ | 576.3 |  |  | $ | — |  |  | $ | 576.3 |
|  | Year Ended
|  | December 31, 2020
|  | Previously Reported |  | Other Adjustments |  | As Revised
Operating Activities |  |  |  |  |  |
Net income |  | $ | 305.1 |  |  | $ | 0.7 |  |  | $ | 305.8 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |  |  |
Stock-based compensation expense |  | 51.0 |  |  | 0.8 |  |  | 51.8 |
Depreciation and amortization |  | 114.5 |  |  | — |  |  | 114.5 |
Change in fair value of contingent obligations, net |  | 31.7 |  |  | — |  |  | 31.7 |
Amortization of deferred financing costs |  | 3.5 |  |  | — |  |  | 3.5 |
Impairments |  | 29.0 |  |  | — |  |  | 29.0 |
Deferred income taxes |  | (2.4) |  |  | (0.9) |  |  | (3.3) |
Other |  | (5.2) |  |  | (0.4) |  |  | (5.6) |
Changes in operating assets and liabilities: |  |  |  |  |  |
Accounts receivable |  | 49.0 |  |  | (21.5) |  |  | 27.5 |
Inventories |  | (83.2) |  |  | 16.3 |  |  | (66.9) |
Prepaid expenses and other assets |  | (29.2) |  |  | 2.3 |  |  | (26.9) |
Accounts payable |  | 18.7 |  |  | 9.6 |  |  | 28.3 |
Accrued expenses and other liabilities |  | 19.4 |  |  | (10.9) |  |  | 8.5 |
Accrued compensation |  | 21.8 |  |  | — |  |  | 21.8 |
Income taxes receivable and payable, net |  | 1.1 |  |  | 4.9 |  |  | 6.0 |
Contract liabilities |  | 11.2 |  |  | — |  |  | 11.2 |
Net cash provided by operating activities |  | 536.0 |  |  | 0.9 |  |  | 536.9 |
Investing Activities |  |  |  |  |  |
Purchases of property, plant and equipment |  | (141.0) |  |  | (0.9) |  |  | (141.9) |
Milestone payment from prior asset acquisition |  | (10.0) |  |  | — |  |  | (10.0) |
Net cash used in investing activities |  | (151.0) |  |  | (0.9) |  |  | (151.9) |
Financing Activities |  |  |  |  |  |
Proceeds from senior unsecured notes |  | 450.0 |  |  | — |  |  | 450.0 |
Principal payments on revolving credit facility |  | (373.0) |  |  | — |  |  | (373.0) |
Principal payments on term loan facility |  | (14.1) |  |  | — |  |  | (14.1) |
Proceeds from stock-based compensation activity |  | 31.6 |  |  | — |  |  | 31.6 |
Taxes paid for stock-based compensation activity |  | (13.8) |  |  | — |  |  | (13.8) |
Debt issuance costs |  | (8.4) |  |  | — |  |  | (8.4) |
Contingent consideration payments |  | (2.8) |  |  | — |  |  | (2.8) |
Net cash provided by financing activities: |  | 69.5 |  |  | — |  |  | 69.5 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  | (1.0) |  |  | — |  |  | (1.0) |
Net change in cash, cash equivalents and restricted cash |  | 453.5 |  |  | — |  |  | 453.5 |
Cash, cash equivalents and restricted cash, beginning of period |  | 168.0 |  |  | — |  |  | 168.0 |
Cash, cash equivalents and restricted cash, end of period |  | $ | 621.5 |  |  | $ | — |  |  | $ | 621.5 |
Supplemental disclosure of cash flow information: |  |  |  |  |  |
Cash paid for interest |  | $ | 21.0 |  |  | $ | — |  |  | $ | 21.0 |
Cash paid for income taxes |  | $ | 109.3 |  |  | $ | — |  |  | $ | 109.3 |
Supplemental information on non-cash investing and financing activities: |  |  |  |  |  |
Purchases of property, plant and equipment unpaid at period end |  | $ | 22.0 |  |  | $ | 0.9 |  |  | $ | 22.9 |
Reconciliation of cash and cash equivalents and restricted cash: |  |  |  |  |  |
Cash and cash equivalents |  | $ | 621.3 |  |  | $ | — |  |  | $ | 621.3 |
Restricted cash |  | 0.2 |  |  | — |  |  | 0.2 |
Total |  | $ | 621.5 |  |  | $ | — |  |  | $ | 621.5 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting error correction. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794 + Details
Name: | us-gaap_ErrorCorrectionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration